Suppr超能文献

口腔舌鳞状细胞癌患者的非根治性治疗

Non-curative treatment of patients with oral tongue squamous-cell carcinoma.

作者信息

Mroueh R, Haapaniemi A, Saarto T, Grönholm L, Grénman R, Salo T, Mäkitie A A

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and HUS Helsinki University Hospital, P.O. Box 263, 00029 HUS, FI-00029, Finland.

Department of Oncology, University of Helsinki and HUS Helsinki University Hospital, Helsinki, Finland.

出版信息

Eur Arch Otorhinolaryngol. 2019 Jul;276(7):2039-2045. doi: 10.1007/s00405-019-05456-y. Epub 2019 May 8.

Abstract

PURPOSE

Late-stage OTSCC is associated with poor overall survival (OS). Non-curative treatment approach aims to improve quality of life and prolong survival of patients deemed incurable. The purpose of this study was to investigate the used non-curative treatment modalities for OTSSC and patient survival.

METHODS

All patients diagnosed with OTSCC and treated with non-curative intent at the HUS Helsinki University Hospital (Helsinki, Finland) during the 12-year period of 2005-2016 were included. Survival analysis after the non-curative treatment decision was conducted using the Kaplan-Meier method in this population-based study.

RESULTS

Eighty-two patients were identified. A non-curative treatment decision was made at presentation without any previous treatment in 26 patients (7% of all patients diagnosed with OTSCC during the study period). Palliative radiotherapy was administered to 24% of all patients. The average survival time after the non-curative treatment decision was 3.7 months (median 2 and range 0-26).

CONCLUSIONS

Due to the short mean survival time after decision for treatment with non-curative intent, and the notable symptom burden in this patient population, a prompt initiation of all non-curative measures is warranted.

摘要

目的

晚期口腔鳞状细胞癌(OTSCC)患者的总生存期(OS)较差。非根治性治疗方法旨在提高被认为无法治愈患者的生活质量并延长其生存期。本研究的目的是调查OTSCC的非根治性治疗方式及患者的生存期。

方法

纳入2005年至2016年这12年间在芬兰赫尔辛基大学医院(HUS)被诊断为OTSCC并接受非根治性治疗的所有患者。在这项基于人群的研究中,采用Kaplan-Meier方法对非根治性治疗决策后的生存期进行分析。

结果

共识别出82例患者。26例患者(占研究期间所有诊断为OTSCC患者的7%)在初诊时未经任何治疗即做出了非根治性治疗决策。24%的患者接受了姑息性放疗。非根治性治疗决策后的平均生存时间为3.7个月(中位数为2个月,范围为0至26个月)。

结论

由于非根治性治疗决策后的平均生存时间较短,且该患者群体症状负担明显,因此有必要迅速启动所有非根治性治疗措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b56a/6581924/09a954bb212c/405_2019_5456_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验